NIA Home > Research > Conferences, Workshops & Meetings > Workshop Report
Print this page E-mail this page

Goal and Objectives

In this workshop senior cancer center representatives (i.e., center directors, individual researchers, science administrators, scientific program directors) explored the expertise and resources of the cancer centers that can be organized to generate research on the aging/cancer interface. The NCI Cancer Centers Program supports major academic and research institutions throughout the United States to sustain broad-based, coordinated, interdisciplinary programs in cancer research, and also promotes inter-institute studies and collaborations among investigators in oncology and geriatric medicine and investigators of the biology of aging and cancer. The workshop setting was meant to provide a forum for constructive brainstorming and to obtain a productive exchange of ideas among participants from varying disciplines and professions who were invited to share their perspectives.

The goal of the workshop was to identify a concise set of research priorities to facilitate the interface of aging and cancer research so that scientific pathways can be established to reduce the magnitude of the cancer burden for older Americans.

The objectives of the NIA/NCI cosponsored workshop were to:

  1. Identify promising scientific areas at the aging/cancer research interface that could be pursued in the cancer centers, given their unique resources and expertise.
     
  2. Recommend research opportunities in aging and cancer research (considering each working group's theme) that will advance medical progress at the aging/cancer research inter face. In each working group, the top three research priorities were selected.
     
  3. Suggest various strategies and approaches for integrating aging and cancer research on behalf of older persons (i.e., a research plan of action).

Charge to the Working Groups

  • Each working group was charged with nominating the three highest research priorities out of all opportunities and needs discussed.
     
  • Group deliberations on the research themes also addressed the following factors in their report during the plenary session:
     
    • Barriers to research progress (e.g., lack of sufficiently trained researchers and clinicians, insufficient technology, organizational infrastructure, inadequate funding, complexity of the older patient's situation, research problem definition, lack of leadership or expertise)
       
    • Mechanisms to facilitate research progress (e.g., evaluation tools to assist in the assessment of prognosis and treatment of older cancer patients, development and standardization of alterations or modifications of cancer treatment modalities in older patients because of comorbidity, ways to enhance participation of older persons in clinical studies, novel funding mechanisms as incentives for conducting research on cancer in the elderly)

Research Topics

Many excellent ideas emanated from the August 10, 2000, workshop planning meeting and are incorporated within the seven themes for the breakout sessions. Other ideas were introduced by individuals in the breakout group discussions. Among the suggestions for themes that emerged within the planning group were:

  • patterns of care studies;
  • pharmacology of anti-cancer agents in older patients;
  • prospective studies of surgical and radiation treatment in individuals with varying age-related functional limitations;
  • activities of new drug and biologic anti-cancer agents in older patients;
  • follow-up studies on adverse effects of treatment in older and younger patients;
  • single institution and/or multicenter clinical trials;
  • Phase IV trials (standard therapy outcome) to improve management of older cancer patients;
  • characterization of older patients ineligible for treatment protocols;
  • correlative research studies;
  • cancer-site specific studies (e.g., refinement of current characterization of different tumors in relation to aging);
  • effective management of older cancer patients with preexisting chronic conditions and concurrent diseases (i.e., comorbidity);
  • studies of mechanisms of carcinogenesis and senescence and their overlap;
  • coping with psychosocial, social, and medical effects of cancer and its treatment; and
  • palliative care, pain management, and end of life issues.

The cancer centers also have many existing databases that could be examined for insights into generate hypotheses (tissue bank data) and treatment patterns (e.g., in-house tumor registries).

Research Themes Selected

Patterns of Care

[studies with a focus on older patients using both prospective and retrospective data that could include community-based studies, patient management, and cancer site-specific studies as well as maximizing existing data (e.g., SEER special studies, HCFA linkage, tissue banks, family network studies)]
 
Speaker: Vincent Mor, Ph.D., Brown University
 
Co-Chairs: Paul F. Engstrom, M.D., Fox Chase Cancer Center and Jerome W. Yates, M.D., M.P.H., Roswell Park Cancer Institute
 

Treatment Efficacy and Tolerance

[e.g., clinical trials, pharmacology of anti-cancer drugs, radiation therapy, surgery, available technology, other modalities, characterization of older patients ineligible for clinical trials]
 
Speaker: Richard L. Schilsky, M.D., University of Chicago
 
Co-Chairs: Richard L. Schilsky, M.D., University of Chicago and Joel E. Tepper, M.D., University of North Carolina School of Medicine
 

Effects of Comorbidity on Cancer

[e.g., studies could include problems of diagnosis and treatment, disability, functional limitations, assessment, recurrence, detection of second primaries]
 
Speaker: William A. Satariano, Ph.D., M.P.H., University of California, Berkeley
 
Co-Chairs: Hyman B. Muss, M.D., University of Vermont and Kathy Albain, M.D., Loyola University
 

Prevention, Risk Assessment, and Screening

[impediments for older-aged persons (asymptomatic or symptomatic precluding their entrance into the preventive and health care system (e.g., delay behavior, insufficient knowledge of cancer risk), changes that occur in cancer risk as a function of aging]
 
Speakers: Jeanne Mandelblatt, M.D., M.P.H., and Lodovico Balducci, M.D., H. Lee Moffit Cancer Center
 
Co-Chairs: Jeanne Mandelblatt, M.D., M.P.H., Lombardi Cancer Center and Lodovico Balducci, M.D., H. Lee Moffit Cancer Center
 

Psychological, Social, and Medical Issues

[e.g., quality of life, quality of cancer survival, family and caregiver resources, early and late effects of treatment, quality cancer care, tumor recurrence, multiple primary tumors]
 
Speaker: Alice B. Kornblith, Ph.D., Dana-Farber Cancer Institute
 
Co-Chairs: Patricia A. Ganz, M.D. (Keynote Speaker) Jonsson Comprehensive Cancer Center, University of California, Los Angeles and Alice B. Kornblith, Ph.D., Dana-Farber Cancer Institute
 

Palliative Care, End of Life Care, and Pain Relief

[e.g., studies focused on patients with advanced cancer and associated issues in palliative care including caregiver and family support]
 
Speaker: Kathleen M. Foley, M.D., Memorial Sloan-Kettering Cancer Center
 
Co-Chairs: Nora Janjan, M.D., University of Texas, M.D. Anderson Cancer Center and Ruth McCorkle, Ph.D., F.A.A.N., Yale University
 

Biology of Aging and Cancer

[e.g., genetics, molecular signatures, bench to bedside application, translational research, age-related changes as they contribute to mortality, a focus on older persons who are vulnerable to cancer as contrasted with those who are not (i.e., sibship studies)]
 
Speaker: William B. Ershler, M.D., Institute for Advanced Studies in Aging and Geriatric Medicine
 
Co-Chairs: Harvey Jay Cohen, M.D.( Keynote Speaker), Duke University Medical Center and Derek Raghavan, M.D., Ph.D., University of Southern California, Norris Comprehensive Cancer Center

Page last updated Feb 16, 2008